FDA panel recommends new diet drug Qnexa OKs previously rejected weightloss pill advisors endorse If gets the green light who would get U.S. advisers back experimental obesity 1st in 13 years initial OK Vivus WeightLoss Pill Wins Backing of Panel Diet should be approved says Drug Advisory Panel’s Support Backs At hearing public commenters are split on drug's value Video backs Vivus’s

Panel recommends FDA OK obesity drug Qnexa Experimental obesity drug Qnexa won the backing of U.S. health advisers, raising hopes for approval of the first prescription weight-loss pill in 13 years. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel Vivus Inc.'s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. The shares doubled in late trading. FDA advisors endorse weight-loss drug Qnexa In a reversal, an FDA advisory committee backs the weight-loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999. Diet drug Qnexa should be approved, panel says The diet drug Qnexa has cleared a major hurdle toward eventual Food and Drug Administration approval. An independent panel of medical experts who advise the agency voted Wednesday that Qnexa's significant weight-loss benefit outweighed its potential risks. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Advisory Panel Vivus Inc. (VVUS) 's weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. If Qnexa gets the green light, who would get the drug? An advisory committee's hearty 20-to-2 vote to recommend approval of the obesity drug Qnexa on Wednesday means it's highly likely the FDA will allow the medication to be marketed when the agency issues its final report later this year. If approved, Qnexa will be the first new prescription weight-loss medication in 13 years. At Qnexa hearing, public commenters are split on the drug's value Qnexa, an investigational drug to promote weight loss, has divided public health advocates, based on comments made Wednesday at a Food and Drug Administration advisory committee hearing. FDA Weighs Fate of Qnexa for Weight Loss, Again WEDNESDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects. Qnexa Weight-Loss Drug Wins Advisory Panel's Support A committee recommended that the Food and Drug Administration approve what could become the first new prescription drug to treat obesity in 13 years. Qnexa Weight Loss Pill Wins Support From FDA Panel Qnexa, a previously rejected weight loss pill, won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a decade....
Key Words: qnexa

References:
http://www.philly.com/r?19=961&43=165801&44=140090733&32=3796&7=195352&40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fbusiness%2F20120223_FDA_panel_recommends_new_diet_drug_Qnexa.html
http://feedproxy.google.com/~r/orlandosentinel/news/local/southwest/~3/Qg4sLpAyIGc/sns-bc-us--dietpill-fdameeting,0,6216893.story
http://www.businessweek.com/news/2012-02-23/vivus-weight-loss-pill-qnexa-wins-backing-of-fda-panel.html
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1cdbd44a/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Efda0E20A120A2220H0A0H73133580Bstory0Dtrack0Frss/story01.htm
http://video.msnbc.msn.com/nightly-news/46489035/
http://rssfeeds.usatoday.com/~r/usatoday-NewsTopStories/~3/wxHzKHaW-FE/1
http://pixelhat.net/